...
首页> 外文期刊>Chinese Medical Journal >LIMB SALVAGE IN PRIMARY MALIGNANT BONE TUMORS BY INTRAOPERATIVE MICROWAVE HEAT TREATMENT
【24h】

LIMB SALVAGE IN PRIMARY MALIGNANT BONE TUMORS BY INTRAOPERATIVE MICROWAVE HEAT TREATMENT

机译:术中微波加热治疗原发性恶性骨肿瘤的肢体。

获取原文
获取原文并翻译 | 示例

摘要

Objective. To use intraoperative microwave heat for the treatment of tumor-bearing bone in situ for limb-salvage in primary malignant bone tumor. Patients and Methods. Twenty-five patients with malignant bone tumor received surgical protocol for limb-salvage by wide exposure and intraoperative microwave heat treatment of tumor bone in situ. The tumor was localized at distal femur in 16 patients, proximal tibia in 5, shaft of femur in 2, and illia in 2. Results. The pathological diagnosis revealed osteosar-coma in 16 patients, parosteal osteosarcoma in 4. chondrosarcoma in 3, and leiomyosarcoma in 2. The stage of tumor was classified into IIB in 16 patients, IIA in 6, and IIIB in 3. The operative technique was wide exposure for tumor in soft tissues, protecting the surrounding normal tissue from heat injury by copper mesh, and heating tumor-bearing bone at 50 ℃ for 15 minutes. The patients were followed up from 4 to 180 months (mean, 63 months). The survival rate of 2, 5 and 10 years was 81.3%, 70.4%, and 53.8% respectively. The functional results were less than 50% in 4 patients, between 50% and 75% in 9, and more than 75% in 12, referred to the normal function of a normal limb. The complications consisted of infection in 4 patients, pathological fracture in 4, and separation of epiphysis in 1. Oncological results showed that local recurrences of tumor were in 4 patients, and 6 patients suffered from distant metastasis. Conclusion. The treatment is an alternative to replacement by prosthesis or allograft bridging techniques.
机译:目的。术中用微波加热原位治疗原发性恶性骨肿瘤中的带瘤骨。患者和方法。 25例恶性骨肿瘤患者接受了广泛暴露和术中微波加热原位肿瘤修复肢体的手术方案。肿瘤位于股骨远端16例,胫骨近端5例,股骨干2例,骨2例。病理诊断为骨肉瘤16例,骨骨肉瘤4例,软骨肉瘤3例,平滑肌肉瘤2例。肿瘤分期为IIB 16例,IIA 6例,IIIB 3例。广泛暴露于软组织中的肿瘤,通过铜网保护周围的正常组织免受热损伤,并在50℃下加热荷瘤骨15分钟。随访4至180个月(平均63个月)。 2年,5年和10年的生存率分别为81.3%,70.4%和53.8%。 4名患者的功能结果低于正常肢体的正常功能,其中4名患者的少于50%,9名患者的介于50%至75%之间,而12名患者的大于75%。并发症包括感染4例,病理性骨折4例,骨physi分离1例。肿瘤学结果显示,肿瘤局部复发4例,远处转移6例。结论。该治疗是通过假体或同种异体桥接技术替代的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号